The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP

Br J Pharmacol. 1994 Jul;112(3):946-50. doi: 10.1111/j.1476-5381.1994.tb13172.x.

Abstract

1. Extracellular adenosine triphosphate (ATP) is known to open a receptor-operated ion channel (P2Z class) in human lymphocytes which conducts a range of cationic permeants. The activity of a range of different agonists and inhibitors towards the P2Z-purinoceptor was investigated by measuring the agonist-induced influx of Ba2+ into fura-2 loaded lymphocytes. 2. The most potent agonist was 2' & 3'-0-(4-benzoylbenzoyl)-ATP (benzoylbenzoic ATP) which gave 2 fold greater maximum Ba2+ influx and had a 10 fold lower EC50 than for ATP. The rank order of agonist potency in K(+)-media was benzoylbenzoic ATP >> ATP = 2-methylthio ATP = 2-chloro ATP > ATP-gamma-S. ADP, UTP and alpha,beta-methylene ATP were unable to stimulate Ba2+ influx. 3. Extracellular Na+ inhibited the increment of Ba2+ influx induced by all concentrations of ATP, 2-methylthio ATP, 2-chloroATP and ATP-gamma-S. This inhibitory effect of extracellular Na+ is also reflected in the different EC50s for benzoylbenzoic ATP (8 microM in K(+)-media, 18 microM in Na(+)-media) but the maximal response to this agonist was the same in the presence or absence of Na+. 4. Treatment of lymphocytes with 2,3 dialdehyde ATP (oxidized ATP0 at 300 microM for 60 min gave total and irreversible inhibition of ATP-induced Ba2+ influx. 5'-p-Fluorosulphonyl benzoyladenosine (FSBA) also was an irreversible inhibitor but the maximal inhibition achieved was 90%. 5. It is concluded that the P2z-purinoceptor of human lymphocytes has a rank order of agonist potency which clearly distinguishes it from other P2-receptors and that oxidized ATP is a convenient irreversible inhibitor for the P2Z-purinoceptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Barium / metabolism
  • Calcium / metabolism
  • Culture Media
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Fluorometry
  • Humans
  • In Vitro Techniques
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism
  • Lymphocytes / drug effects
  • Lymphocytes / metabolism*
  • Oxidation-Reduction
  • Potassium / pharmacology
  • Purine Nucleotides / pharmacology*
  • Purinergic P2 Receptor Agonists*
  • Purinergic P2 Receptor Antagonists*
  • Sodium / pharmacology
  • Tumor Cells, Cultured

Substances

  • Culture Media
  • Purine Nucleotides
  • Purinergic P2 Receptor Agonists
  • Purinergic P2 Receptor Antagonists
  • Barium
  • Adenosine Triphosphate
  • Sodium
  • Potassium
  • Calcium